AMLX · Amylyx Pharmaceuticals, Inc.
$18.50
+1.05 (+6.02%)
At close · Jul 21
Market Cap
$2.06B
Shares
111.19M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-22 | 13,556 | $15.67 | $212,423 |
| 2026-06-15 | 186 | $14.59 | $2,714 |
| 2026-06-04 | 3 | $13.20 | $40 |
| 2026-06-02 | 40 | $14.07 | $563 |
| 2026-06-01 | 13,737 | $14.35 | $197,126 |
| 2026-05-22 | 13 | $13.93 | $181 |
| 2026-05-19 | 36 | $12.86 | $463 |
| 2026-05-18 | 8,340 | $13.29 | $110,839 |
| 2026-05-13 | 16,807 | $14.44 | $242,693 |
| 2026-04-30 | 347 | $15.60 | $5,413 |
Showing 1–10 of 10 settlements
Key facts
CIK
1658551
CUSIP
03237H101
13F (30d)
10 filings
10 filers
Visit website
Investor relations